ILP-2 Antikörper (AA 1-236)
Kurzübersicht für ILP-2 Antikörper (AA 1-236) (ABIN7145212)
Target
Alle ILP-2 (BIRC8) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-236
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Baculoviral IAP repeat-containing protein 8 protein (1-236AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ILP-2 (BIRC8) (Baculoviral IAP Repeat-Containing 8 (BIRC8))
-
Andere Bezeichnung
- BIRC8
-
Hintergrund
-
Background: Protects against apoptosis mediated by BAX.
Aliases: Baculoviral IAP repeat containing 8 antibody, Baculoviral IAP repeat containing protein 8 antibody, Baculoviral IAP repeat-containing protein 8 antibody, BIRC 8 antibody, BIRC8 antibody, BIRC8 protein antibody, BIRC8_HUMAN antibody, hILP 2 antibody, hILP2 antibody, IAP like protein 2 antibody, IAP-like protein 2 antibody, ILP 2 antibody, ILP-2 antibody, Inhibitor of apoptosis like protein 2 antibody, Inhibitor of apoptosis-like protein 2 antibody, Testis specific inhibitor of apoptosis antibody, Testis-specific inhibitor of apoptosis antibody
-
UniProt
- Q96P09
Target
-